Logo image of CLB

CORE LABORATORIES INC (CLB) Stock Fundamental Analysis

NYSE:CLB - New York Stock Exchange, Inc. - US21867A1051 - Common Stock - Currency: USD

12.23  -0.21 (-1.69%)

Fundamental Rating

4

CLB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 62 industry peers in the Energy Equipment & Services industry. CLB has an average financial health and profitability rating. CLB is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CLB had positive earnings in the past year.
CLB had a positive operating cash flow in the past year.
CLB had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CLB had a positive operating cash flow.
CLB Yearly Net Income VS EBIT VS OCF VS FCFCLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

CLB has a Return On Assets (4.74%) which is comparable to the rest of the industry.
CLB has a better Return On Equity (11.06%) than 64.52% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.43%, CLB is in the better half of the industry, outperforming 69.35% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CLB is in line with the industry average of 8.42%.
The 3 year average ROIC (8.80%) for CLB is below the current ROIC(9.43%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.74%
ROE 11.06%
ROIC 9.43%
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
CLB Yearly ROA, ROE, ROICCLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

CLB has a Profit Margin (5.41%) which is in line with its industry peers.
In the last couple of years the Profit Margin of CLB has declined.
CLB's Operating Margin of 11.14% is in line compared to the rest of the industry. CLB outperforms 56.45% of its industry peers.
In the last couple of years the Operating Margin of CLB has declined.
Looking at the Gross Margin, with a value of 19.77%, CLB is doing worse than 70.97% of the companies in the same industry.
CLB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.14%
PM (TTM) 5.41%
GM 19.77%
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
CLB Yearly Profit, Operating, Gross MarginsCLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CLB is still creating some value.
CLB has about the same amout of shares outstanding than it did 1 year ago.
CLB has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CLB has an improved debt to assets ratio.
CLB Yearly Shares OutstandingCLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CLB Yearly Total Debt VS Total AssetsCLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.84 indicates that CLB is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.84, CLB is doing good in the industry, outperforming 75.81% of the companies in the same industry.
CLB has a debt to FCF ratio of 2.83. This is a good value and a sign of high solvency as CLB would need 2.83 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 2.83, CLB is doing good in the industry, outperforming 66.13% of the companies in the same industry.
A Debt/Equity ratio of 0.49 indicates that CLB is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.49, CLB perfoms like the industry average, outperforming 46.77% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 2.83
Altman-Z 2.84
ROIC/WACC1
WACC9.41%
CLB Yearly LT Debt VS Equity VS FCFCLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

CLB has a Current Ratio of 2.21. This indicates that CLB is financially healthy and has no problem in meeting its short term obligations.
CLB has a better Current ratio (2.21) than 67.74% of its industry peers.
CLB has a Quick Ratio of 1.64. This is a normal value and indicates that CLB is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.64, CLB is in the better half of the industry, outperforming 66.13% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 1.64
CLB Yearly Current Assets VS Current LiabilitesCLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

CLB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.47%.
CLB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.14% yearly.
The Revenue has been growing slightly by 1.32% in the past year.
The Revenue has been decreasing by -4.75% on average over the past years.
EPS 1Y (TTM)2.47%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-26.32%
Revenue 1Y (TTM)1.32%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%-4.67%

3.2 Future

CLB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.78% yearly.
CLB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.47% yearly.
EPS Next Y-11.91%
EPS Next 2Y-3.25%
EPS Next 3Y-0.94%
EPS Next 5Y12.78%
Revenue Next Year-3.25%
Revenue Next 2Y-0.21%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLB Yearly Revenue VS EstimatesCLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M 1B
CLB Yearly EPS VS EstimatesCLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.73, which indicates a correct valuation of CLB.
The rest of the industry has a similar Price/Earnings ratio as CLB.
When comparing the Price/Earnings ratio of CLB to the average of the S&P500 Index (27.51), we can say CLB is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 14.85, the valuation of CLB can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLB indicates a slightly more expensive valuation: CLB is more expensive than 62.90% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.58. CLB is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 14.73
Fwd PE 14.85
CLB Price Earnings VS Forward Price EarningsCLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CLB's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. CLB is more expensive than 83.87% of the companies in the same industry.
CLB's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 13.04
EV/EBITDA 9.45
CLB Per share dataCLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.25%
EPS Next 3Y-0.94%

3

5. Dividend

5.1 Amount

CLB has a yearly dividend return of 0.31%, which is pretty low.
Compared to an average industry Dividend Yield of 3.52, CLB has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.35, CLB's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.31%

5.2 History

The dividend of CLB decreases each year by -55.13%.
CLB has paid a dividend for at least 10 years, which is a reliable track record.
CLB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-55.13%
Div Incr Years0
Div Non Decr Years3
CLB Yearly Dividends per shareCLB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

CLB pays out 6.70% of its income as dividend. This is a sustainable payout ratio.
DP6.7%
EPS Next 2Y-3.25%
EPS Next 3Y-0.94%
CLB Yearly Income VS Free CF VS DividendCLB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M
CLB Dividend Payout.CLB Dividend Payout, showing the Payout Ratio.CLB Dividend Payout.PayoutRetained Earnings

CORE LABORATORIES INC

NYSE:CLB (7/15/2025, 10:35:03 AM)

12.23

-0.21 (-1.69%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)04-23 2025-04-23/amc
Earnings (Next)07-23 2025-07-23/amc
Inst Owners117.5%
Inst Owner Change0%
Ins Owners1.04%
Ins Owner Change3.93%
Market Cap573.34M
Analysts50
Price Target14.89 (21.75%)
Short Float %16.01%
Short Ratio15.07
Dividend
Industry RankSector Rank
Dividend Yield 0.31%
Yearly Dividend0.04
Dividend Growth(5Y)-55.13%
DP6.7%
Div Incr Years0
Div Non Decr Years3
Ex-Date05-05 2025-05-05 (0.01)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.47%
Min EPS beat(2)-4.67%
Max EPS beat(2)-0.26%
EPS beat(4)2
Avg EPS beat(4)1.95%
Min EPS beat(4)-4.67%
Max EPS beat(4)7.15%
EPS beat(8)4
Avg EPS beat(8)3.65%
EPS beat(12)7
Avg EPS beat(12)4.64%
EPS beat(16)7
Avg EPS beat(16)1.87%
Revenue beat(2)0
Avg Revenue beat(2)-2.65%
Min Revenue beat(2)-3.38%
Max Revenue beat(2)-1.92%
Revenue beat(4)0
Avg Revenue beat(4)-1.99%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)-0.73%
Revenue beat(8)1
Avg Revenue beat(8)-1.71%
Revenue beat(12)2
Avg Revenue beat(12)-1.5%
Revenue beat(16)3
Avg Revenue beat(16)-1.54%
PT rev (1m)-1.35%
PT rev (3m)-18.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.38%
EPS NY rev (1m)-3.7%
EPS NY rev (3m)-10.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.74%
Revenue NY rev (1m)-0.85%
Revenue NY rev (3m)-4.96%
Valuation
Industry RankSector Rank
PE 14.73
Fwd PE 14.85
P/S 1.11
P/FCF 13.04
P/OCF 9.97
P/B 2.26
P/tB 3.88
EV/EBITDA 9.45
EPS(TTM)0.83
EY6.79%
EPS(NY)0.82
Fwd EY6.74%
FCF(TTM)0.94
FCFY7.67%
OCF(TTM)1.23
OCFY10.03%
SpS11.05
BVpS5.41
TBVpS3.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.74%
ROE 11.06%
ROCE 11.82%
ROIC 9.43%
ROICexc 9.87%
ROICexgc 12.77%
OM 11.14%
PM (TTM) 5.41%
GM 19.77%
FCFM 8.49%
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
ROICexc(3y)9.11%
ROICexc(5y)8.99%
ROICexgc(3y)11.75%
ROICexgc(5y)11.63%
ROCE(3y)11.03%
ROCE(5y)10.9%
ROICexcg growth 3Y11.32%
ROICexcg growth 5Y-6.37%
ROICexc growth 3Y11.52%
ROICexc growth 5Y-2.86%
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
F-Score6
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 2.83
Debt/EBITDA 1.72
Cap/Depr 91.42%
Cap/Sales 2.62%
Interest Coverage 5.86
Cash Conversion 79.34%
Profit Quality 156.87%
Current Ratio 2.21
Quick Ratio 1.64
Altman-Z 2.84
F-Score6
WACC9.41%
ROIC/WACC1
Cap/Depr(3y)71.15%
Cap/Depr(5y)68.67%
Cap/Sales(3y)2.22%
Cap/Sales(5y)2.39%
Profit Quality(3y)84.24%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.47%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-26.32%
EPS Next Y-11.91%
EPS Next 2Y-3.25%
EPS Next 3Y-0.94%
EPS Next 5Y12.78%
Revenue 1Y (TTM)1.32%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%-4.67%
Revenue Next Year-3.25%
Revenue Next 2Y-0.21%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%
EBIT growth 1Y-4.22%
EBIT growth 3Y11.62%
EBIT growth 5Y-8.87%
EBIT Next Year11.28%
EBIT Next 3Y4.07%
EBIT Next 5Y17.46%
FCF growth 1Y586.92%
FCF growth 3Y23.36%
FCF growth 5Y-8.39%
OCF growth 1Y248.59%
OCF growth 3Y15.5%
OCF growth 5Y-8.83%